PCI Biotech pivotal study for FimaChem


PCI Biotech pivotal study for FimaChem in Inoperable Cholangiocarcinoma https://www.clinicaltrialsregister.eu/ctr-search/search?query=2018-002647-29

"Randomised, Open-Label, Phase 2 to Assess the Safety, Tolerability and Efficacy of Fimaporfin-Induced Photochemical Internalisation of Gemcitabine...."
Redigert 11.02.2019 kl 14:48 Du må logge inn for å svare